Abrdn PLC Royalty Pharma PLC Transaction History

Abrdn PLC

$50.5 Billion
Q1 2025

A detailed history of Abrdn PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Abrdn PLC holds 213,860 shares of RPRX stock, worth $7.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

213,860

Previous 89,667 138.5%

Holding current value

$7.02 Million

Previous $2.29 Million 191.08%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$25.75 - $33.86 $3.2 Million - $4.21 Million	124,193 Added 138.5%	213,860 $6.66 Million
Q4 2024 Jan 24, 2025	SELL	$24.28 - $28.39 $356,551 - $416,907	-14,685 Reduced 14.07%	89,667 $2.29 Million
Q3 2024 Oct 24, 2024	SELL	$25.63 - $29.27 $27.8 Million - $31.7 Million	-1,083,657 Reduced 91.22%	104,352 $2.95 Million
Q2 2024 Aug 09, 2024	SELL	$26.26 - $29.9 $2.9 Million - $3.3 Million	-110,391 Reduced 8.5%	1,188,009 $31.3 Million
Q1 2024 May 08, 2024	BUY	$27.46 - $31.33 $1.13 Million - $1.29 Million	41,032 Added 3.26%	1,298,400 $39.4 Million
Q4 2023 Jan 31, 2024	SELL	$26.21 - $29.22 $64.2 Million - $71.5 Million	-2,448,301 Reduced 66.07%	1,257,368 $35.3 Million
Q3 2023 Nov 06, 2023	SELL	$26.26 - $31.38 $4.45 Million - $5.32 Million	-169,484 Reduced 4.37%	3,705,669 $101 Million
Q2 2023 Jun 20, 2024	SELL	$29.6 - $36.56 $3.06 Million - $3.78 Million	-103,262 Reduced 2.6%	3,875,153 $119 Million
Q2 2023 Aug 04, 2023	SELL	$29.6 - $36.56 $3.06 Million - $3.78 Million	-103,262 Reduced 2.6%	3,875,153 $119 Million
Q1 2023 Jun 20, 2024	BUY	$32.77 - $39.4 $15.1 Million - $18.2 Million	460,938 Added 13.1%	3,978,415 $143 Million
Q1 2023 Apr 28, 2023	BUY	$32.77 - $39.4 $15.1 Million - $18.2 Million	460,938 Added 13.1%	3,978,415 $143 Million
Q4 2022 Jun 20, 2024	BUY	$39.17 - $44.04 $86.9 Million - $97.7 Million	2,219,077 Added 170.91%	3,517,477 $139 Million
Q4 2022 Feb 09, 2023	BUY	$39.17 - $44.04 $3.27 Million - $3.67 Million	83,405 Added 2.43%	3,517,477 $139 Million
Q3 2022 Nov 10, 2022	SELL	$39.88 - $44.65 $5.3 Million - $5.93 Million	-132,822 Reduced 3.72%	3,434,072 $138 Million
Q2 2022 Aug 05, 2022	BUY	$37.53 - $44.22 $49.8 Million - $58.7 Million	1,327,764 Added 59.3%	3,566,894 $150 Million
Q1 2022 May 04, 2022	SELL	$37.46 - $42.44 $1.75 Million - $1.98 Million	-46,769 Reduced 2.05%	2,239,130 $87.5 Million
Q4 2021 Feb 08, 2022	BUY	$35.17 - $42.48 $17 Million - $20.6 Million	484,754 Added 26.91%	2,285,899 $91.1 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $2.99 Million - $3.5 Million	-82,866 Reduced 4.4%	1,801,145 $65.1 Million
Q2 2021 Aug 10, 2021	BUY	$39.85 - $46.63 $73.9 Million - $86.5 Million	1,855,388 Added 6482.16%	1,884,011 $77.2 Million
Q1 2021 May 06, 2021	BUY	$42.34 - $52.82 $779,902 - $972,944	18,420 Added 180.54%	28,623 $1.25 Million
Q4 2020 Feb 10, 2021	BUY	$36.12 - $50.05 $368,532 - $510,660	10,203 New	10,203 $510,000

Others Institutions Holding RPRX

# of Institutions

483

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.4B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account